Cinacalcet HCl controls secondary hyperparathyroidism (HPT) in dialysis patients regardless of disease severity.

被引：0
|
作者：
Quarles, LD
Zeig, S
Spiegel, DM
Silver, MR
Vokes, TJ
Torregrosa, JV
Reichel, H
Horl, WH
Zani, V
Klassen, PS
Olson, KA
Turner, SA
Sprague, SM
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Pines Clin Res, Pembroke Pines, FL USA
[3] Univ Colorado, HSC, Denver, CO 80202 USA
[4] MHMC, CWRU, Cleveland, OH USA
[5] Univ Chicago Hosp, Chicago, IL 60637 USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Nephrol Ctr, Villingen Schwenningen, Germany
[8] Univ Vienna, Innere Med Klin 3, Vienna, Austria
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
[10] Evanston Hosp Corp, Evanston, IL 60201 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：463A / 463A
页数：1
相关论文
共 50 条
  • [31] Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
    Warady, Bradley A.
    Ng, Eric
    Bloss, Laura
    Mo, May
    Schaefer, Franz
    Bacchetta, Justine
    PEDIATRIC NEPHROLOGY, 2020, 35 (09) : 1679 - 1697
  • [32] Cinacalcet HCl decreases PTH and blood ionized calcium in rodent models of chronic renal insufficiency (CRI) accompanied by secondary hyperparathyroidism (HPT).
    Martin, D
    Colloton, M
    Shatzen, E
    Campagnuolo, J
    Padagas, J
    Korach, E
    Rishton, G
    Lacey, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 462A - 462A
  • [33] Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
    Perez-Ricart, Ariadna
    Galicia-Basart, Maria
    Comas-Sugranes, Dolors
    Cruzado-Garrit, Josep-Maria
    Segarra-Medrano, Alfons
    Montoro-Ronsano, Jose-Bruno
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (02) : 229 - 238
  • [34] Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
    Bradley A. Warady
    Eric Ng
    Laura Bloss
    May Mo
    Franz Schaefer
    Justine Bacchetta
    Pediatric Nephrology, 2020, 35 : 1679 - 1697
  • [35] Cinacalcet Treatment for Secondary Hyperparathyroidism in Dialysis Patients: An Observational Study in Routine Clinical Practice
    Bover, Jordi
    Perez, Rafael
    Molina, Manuel
    Benavides, Beatriz
    Ariza, Francisco
    Luis Miguel, Jose
    Tornero, Fernando
    Vicens Torregrosa, Josep
    NEPHRON CLINICAL PRACTICE, 2011, 118 (02): : C109 - C121
  • [36] Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism
    Colloton, M
    Shatzen, E
    Miller, G
    Stehman-Breen, C
    Wada, M
    Lacey, D
    Martin, D
    KIDNEY INTERNATIONAL, 2005, 67 (02) : 467 - 476
  • [37] Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl
    Moe, SM
    Cunningham, J
    Bommer, J
    Adler, S
    Rosansky, SJ
    Urena-Torres, P
    Albizem, MB
    Guo, MD
    Zani, VJ
    Goodman, WG
    Sprague, SM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) : 2186 - 2193
  • [38] USEFULNESS OF RADIOLOGIC EVALUATION TO PREDICT THE RESPONSE OF CINACALCET TREATMENT IN SECONDARY HYPERPARATHYROIDISM OF DIALYSIS PATIENTS
    Ah, Hong Yu
    Jee, Ko Gang
    Yeon, Jung Mi
    Sun, Cho Yoo
    Young, Oh Soo
    Hee, Seo Jae
    Jung, Pyo Heui
    Sangil, Suh
    Joo, Kwon Young
    NEPHROLOGY, 2014, 19 : 131 - 132
  • [39] Effect of correction of secondary hyperparathyroidism by cinacalcet HCl therapy on anemia and EPO consumption in hemodialysis patients
    Cerutti, Roberta
    Castelnovo, Claudia
    Valenti, Giovanni
    Como, Giovanna
    Messa, Piergiorgio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 350 - 350
  • [40] Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
    Block, GA
    Martin, KJ
    de Francisco, ALM
    Turner, SA
    Avram, MM
    Suranyi, MG
    Hercz, G
    Cunningham, J
    Abu-Alfa, AK
    Messa, P
    Coyne, DW
    Locatelli, F
    Cohen, RM
    Evenepoel, P
    Moe, SM
    Fournier, A
    Braun, J
    McCary, LC
    Zani, VJ
    Olson, KA
    Drüeke, TB
    Goodman, WG
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15): : 1516 - 1525
12345